Mokari Atabakinsider trades

In SEC Form 4 filings, Mokari Atabak is listed as Chief Financial Officer of Corcept Therapeutics Inc (CORT). Mokari Atabak reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.

Companies and roles

Company	Role	Transactions	Last filed
CORTCorcept Therapeutics Inc	Chief Financial Officer	3	Sep 3

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-03

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CORTCorcept Therapeutics Inc	Sep 2	Sep 3	F	102	$113.38	$11,565	16,304	No	Form 4
CORTCorcept Therapeutics Inc	Sep 1	Sep 3	A	138	$113.38	$15,646	16,268	No	Form 4
CORTCorcept Therapeutics Inc	Sep 1	Sep 3	A	138	$0.00	$0	16,406	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.